Article
No cognitive or psychological impact from returning research Alzheimer disease biomarkers: A delayed-start, noninferiority, randomized clinical trial
2026-06-01
Abstract excerpt
<h4>Importance</h4> Little is known about the impact of returning Alzheimer disease (AD) biomarkers to cognitively unimpaired (CU) research participants. <h4>Objective</h4> Determine whether return of research results (RoRR) negatively impacts longitudinal symptoms of depression and cognition. <h4>Design</h4> Randomized, noninferiority, delayed-start clinical trial, 2021-2025 <h4>Setting</h4> AD biomarker rese...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 857c026e-040a-5adf-87b1-3ee54951a00d
- DOI
- 10.64898/2026.05.22.26353881
